Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hallucinogens”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Early research (Phase 1)Looking for participantsNCT06450210
What this trial is testing

Safety for Home Administration of Microdose Psilocybin Use

Who this might be right for
Psychedelic Experiences
Johns Hopkins University 20
Testing effectiveness (Phase 2)Study completedNCT04673383
What this trial is testing

SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients

Who this might be right for
Major Depressive Disorder
Small Pharma Ltd 66
Testing effectiveness (Phase 2)Looking for participantsNCT07104916
What this trial is testing

Mindfulness-based Psilocybin Therapy for PTSD

Who this might be right for
Post Traumatic Stress DisorderDepression - Major Depressive Disorder
Anthony P King 30
Early research (Phase 1)Looking for participantsNCT06899334
What this trial is testing

Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 24
Early research (Phase 1)Active Not RecruitingNCT05317689
What this trial is testing

Comparing the Effects of Psilocin and Psilocybin in Healthy Adults

Who this might be right for
Healthy
University of California, San Francisco 20
Testing effectiveness (Phase 2)Study completedNCT05138068
What this trial is testing

Social Anxiety MDMA-Assisted Therapy Investigation

Who this might be right for
Social Anxiety Disorder
Jason B Luoma 90
Very early researchNot Yet RecruitingNCT07565493
What this trial is testing

Psilocybin Administration With 5-HT1a Blockade

Who this might be right for
Psychedelic Effects in Healthy Volunteers
Johns Hopkins University 18
Large-scale testing (Phase 3)Not Yet RecruitingNCT06943573
What this trial is testing

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

Who this might be right for
Bipolar II Depression
Lakshmi N Yatham 90
Early research (Phase 1)Study completedNCT05698095
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers

Who this might be right for
PharmacokineticsSafetyTolerability
Usona Institute 54
Testing effectiveness (Phase 2)Looking for participantsNCT06341426
What this trial is testing

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

Who this might be right for
Major Depressive DisorderDepressionTreatment-Resistant Depression+1 more
University Health Network, Toronto 92
Not applicableUnknownNCT06014164
What this trial is testing

Qualitative Study About Psychedelics Using in Psychiatric Disorders

Who this might be right for
Psychiatric Disorder
University Hospital, Toulouse 25
Early research (Phase 1)Study completedNCT01988311
What this trial is testing

Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

Who this might be right for
PsilocybinHallucinogensPharmacologic Actions+3 more
Johns Hopkins University 10
Testing effectiveness (Phase 2)Study completedNCT06746441
What this trial is testing

Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers

Who this might be right for
Major Depressive Disorder
Khyber Medical University Peshawar 60
Testing effectiveness (Phase 2)Study completedNCT02914769
What this trial is testing

Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression

Who this might be right for
Major Depression
Universidade Federal do Rio Grande do Norte 35
Not applicableStudy completedNCT04965740
What this trial is testing

Exploring Medically Perceived Benefits, Use and Interest in Psychedelics and Cannabinoids

Who this might be right for
PTSDAnxietyAnxiety Disorders+5 more
Empower Research Inc 102
Not applicableUnknownNCT05469243
What this trial is testing

Psychedelic Therapy for Wellness Studies Retrospectively

Who this might be right for
Well Aging
Canadian Forces Health Services Centre Ottawa 100
Testing effectiveness (Phase 2)Looking for participantsNCT07251491
What this trial is testing

Psilocybin to Treat Depression in Spinal Cord Injury

Who this might be right for
Spinal Cord InjuryDepression - Major Depressive DisorderVeteran
James J. Peters Veterans Affairs Medical Center 30
Large-scale testing (Phase 3)Enrolling By InvitationNCT06605105
What this trial is testing

Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

Who this might be right for
Major Depressive Disorder
Cybin IRL Limited 468
Not applicableStudy completedNCT00838305
What this trial is testing

Role of Serotonin in Acute and Subacute MDMA Effects

Who this might be right for
MDMA Mechanism of Action
California Pacific Medical Center Research Institute 13
Very early researchNot Yet RecruitingNCT07449351
What this trial is testing

Psilocybin Microdosing on Cognition, Mood and Quality of Life

Who this might be right for
Psychedelic Microdosing Effects on Mood, Cognition, Subjective Well-being and MRI
Yale University 20
Load More Results